Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1) - Concepedia

Concepedia

Publication | Open Access

Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)

DOI Full Paper Access

22

Citations

15

References

2023

Year

Elizabeth A. Raetz, David T. Teachey, Charles G. Minard, Xiaowei Liu, Robin E. Norris, Kristina Z. Denic, Joel M. Reid, Nikki A. Evensen, Lia Gore, Elizabeth Fox,

Pediatric Blood & Cancer

Abstract

Palbociclib in combination with re-induction chemotherapy was well tolerated with a RP2D of 50 mg/m<sup>2</sup> /day for 21 days. Complete responses were observed among heavily pretreated patients.

References

	Year	Citations

Page 1